Drug Repositioning: The Business Case and Current Strategies to Repurpose Shelved Candidates and Marketed Drugs.
. A Benchmark Dataset for Computational Drug Repositioning. Biomed Data J. 2015;1(2):10-12 .
National Library of Medicine (brackets, no "et al."): . Drug Repositioning: The Business Case and Current Strategies to Repurpose Shelved Candidates and Marketed Drugs. In Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs. Hoboken, NJ: Wiley; 2012. pp. 9-32.
National Library of Medicine (grant proposals with PMCID/PMID): . Drug Repositioning: The Business Case and Current Strategies to Repurpose Shelved Candidates and Marketed Drugs. In Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs. Hoboken, NJ: Wiley; 2012. pp. 9-32.
National Library of Medicine (NLM) - Grant with PMID: . Drug Repositioning: The Business Case and Current Strategies to Repurpose Shelved Candidates and Marketed Drugs. In Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs. Hoboken, NJ: Wiley; 2012. pp. 9-32.
